Glial injury in neurotoxicity after pediatric CD19-directed chimeric antigen receptor T cell therapy.
Glial injury in neurotoxicity after pediatric CD19-directed chimeric antigen receptor T cell therapy.
复制标题
DOI:
10.1002/ana.25502
复制
发表时间:
2019-07
影响因子:
11.2
通讯作者:
中科院分区:
文献类型:
--
作者:
To test whether systemic cytokine release is associated with central nervous system inflammatory responses and glial injury in immune effector cell-associated neurotoxicity syndrome (ICANS) after chimeric antigen receptor (CAR)-T cell therapy in children and young adults. We performed a prospective cohort study of clinical manifestations as well as imaging, pathology, CSF, and blood biomarkers on 43 subjects ages 1 to 25 who received CD19-directed CAR/T cells for acute lymphoblastic leukemia (ALL). Neurotoxicity occurred in 19 of 43 (44%) subjects. Nine subjects (21%) had CTCAE grade 3 or 4 neurological symptoms, with no neurotoxicity-related deaths. Reversible delirium, headache, decreased level of consciousness, tremor, and seizures were most commonly observed. Cornell Assessment of Pediatric Delirium (CAPD) scores ≥9 had 94% sensitivity and 33% specificity for grade ≥3 neurotoxicity, and 91% sensitivity and 72% specificity for grade ≥2 neurotoxicity. Neurotoxicity correlated with severity of cytokine release syndrome, abnormal past brain magnetic resonance imaging (MRI), and higher peak CAR-T cell numbers in blood, but not cerebrospinal fluid (CSF). CSF levels of S100 calcium-binding protein B and glial fibrillary acidic protein increased during neurotoxicity, indicating astrocyte injury. There were concomitant increases in CSF white blood cells, protein, interferon-γ (IFNγ), interleukin (IL)-6, IL-10, and granzyme B (GzB), with concurrent elevation of serum IFNγ IL-10, GzB, granulocyte macrophage colony-stimulating factor, macrophage inflammatory protein 1 alpha, and tumor necrosis factor alpha, but not IL-6. We did not find direct evidence of endothelial activation. Our data are most consistent with ICANS as a syndrome of systemic inflammation, which affects the brain through compromise of the neurovascular unit and astrocyte injury.
登录
查看更多内容
影响因子:
20.3
作者:
Gardner, Rebecca A.;Finney, Olivia;Jensen, Michael C.
通讯作者:
Jensen, Michael C.
影响因子:
28.2
作者:
Gust J;Hay KA;Hanafi LA;Li D;Myerson D;Gonzalez-Cuyar LF;Yeung C;Liles WC;Wurfel M;Lopez JA;Chen J;Chung D;Harju-Baker S;Özpolat T;Fink KR;Riddell SR;Maloney DG;Turtle CJ
通讯作者:
Turtle CJ
影响因子:
82.9
作者:
Giavridis T;van der Stegen SJC;Eyquem J;Hamieh M;Piersigilli A;Sadelain M
通讯作者:
Sadelain M
DOI:
10.1111/bpa.12602
发表时间:
2018-05
期刊:
Brain pathology (Zurich, Switzerland)
影响因子:
--
作者:
Min R;van der Knaap MS
通讯作者:
van der Knaap MS
影响因子:
6
作者:
Gust J;Taraseviciute A;Turtle CJ
通讯作者:
Turtle CJ